Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HRS9531 in Healthy Subjects

NCT05152277 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: HRS9531
OTHER: placebo
DRUG: HRS9531
OTHER: placebo

Sponsor

Fujian Shengdi Pharmaceutical Co., Ltd.